Structural Formula (Image 01)
Methotrexate Sodium Tablet
Product Images NDC 0054-4550
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate Sodium (NDC 0054-4550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Each tablet contains 2.5g methotiate, USP equivalent to 2.74mg methotrerata sodum. This medication should be kept out of reach of children and dispense in a light-resistant, hermetic container as designated in the USPIN. You can store it at 20-28°C (68-77°F); excursions permitted 15-30°C (59-86°F), citing USP Controlled Room Temperature. This medication is a cytotoxic agent. The NDC of the medication is 0054-4550-15 and comes with 36 tablets. Moreover, the pharmacist should dispense it with the attached patient information. The text is about the prescribing information of Methotrexate Tablets, USP by West-Ward Pharmaceuticals Corp. located in Eatontown, NJ 07724.*
Image 03
This is a label and accompanying information for Methotrexate tablets, which are a form of medication used to treat various conditions including cancer and autoimmune diseases. It provides dosage instructions and warnings, and indicates that it is a cytotoxic agent which should be kept away from children. It also includes the name of the pharmaceutical company that produces the medication, West-Ward Pharmaceuticals Corp, and a barcode with a product number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
